Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com
Clinical Trial ID: NCT04408638
A Phase III, Open-Label, Multicenter,Randomized Study Evaluating the Efficacy and Safety of Glofitamab in Combination with Gemcitabine Plus Oxaliplatin Versus Rituximab in Combination with Gemcitabine and Oxaliplatin in Patients with Relapsed/Refractory Diffuse Large BCell Lymphoma
Status
Open
Conditions
Other
Phases
III
Age Group
Adult
Main Investiagtor
Norkin, Maxim
Practice
Lymphoma
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT04408638
Secondary Trial ID Number
GO41944
Keywords
Treatment